| PLEVA, Leos, Pavel KUKLA, Pavlina KUSNIEROVA, Jana ZAPLETALOVA and Ota HLINOMAZ. Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study". Circulation: Cardiovascular Interventions. Philadelphia: Lippincott Williams & Wilkins, 2016, vol. 9, No 9, p. "e004304", 1 pp. ISSN 1941-7640. Available from: https://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004304. |
Other formats:
BibTeX
LaTeX
RIS
@article{1371236,
author = {Pleva, Leos and Kukla, Pavel and Kusnierova, Pavlina and Zapletalova, Jana and Hlinomaz, Ota},
article_location = {Philadelphia},
article_number = {9},
doi = {http://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004304},
keywords = {coronary restenosis; diabetes mellitus; drug-eluting stents; paclitaxel; stents},
language = {eng},
issn = {1941-7640},
journal = {Circulation: Cardiovascular Interventions},
title = {Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study"},
volume = {9},
year = {2016}
}
TY - JOUR
ID - 1371236
AU - Pleva, Leos - Kukla, Pavel - Kusnierova, Pavlina - Zapletalova, Jana - Hlinomaz, Ota
PY - 2016
TI - Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study"
JF - Circulation: Cardiovascular Interventions
VL - 9
IS - 9
SP - "e004304"
EP - "e004304"
PB - Lippincott Williams & Wilkins
SN - 19417640
KW - coronary restenosis
KW - diabetes mellitus
KW - drug-eluting stents
KW - paclitaxel
KW - stents
N2 - We read with great interest the letter by Alfonso et al with comments to our study.1 We know the interesting results of the RIBS V study (Restenosis Intra-Stent of Bare-Metal Stents: Paclitaxel-Eluting Balloon vs. Everolimus-Eluting Stent). Contrary to RIBS V, we used everolimus-eluting stents (EES) with platinum-chromium metallic platform and a different primary end point, 12-month late lumen loss (LLL) in our study.
ER -
PLEVA, Leos, Pavel KUKLA, Pavlina KUSNIEROVA, Jana ZAPLETALOVA and Ota HLINOMAZ. Response by Pleva et al to Letter Regarding Article, ''Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study''. \textit{Circulation: Cardiovascular Interventions}. Philadelphia: Lippincott Williams \&{} Wilkins, 2016, vol.~9, No~9, p.~''e004304'', 1 pp. ISSN~1941-7640. Available from: https://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004304.
|
